Recently, the US Preventive Services Task Force (USPSTF) published a review of the evidence for screening for prostate cancer1 and made a clear recommendation against screening. By giving a grade of “D” in the recommendation statement that was based on this review, the USPSTF concluded that “there is moderate or high certainty that this service has no net benefit or that the harms outweigh the benefits.” 2(p3)
No takes yet. Share an insight, caveat, or question.
Carlsson et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: